Evidence map›Paper›PMID 28742231›Full record

ReviewJournal of neuroscience research2018

Different resuscitation strategies and novel pharmacologic treatment with valproic acid in traumatic brain injury.

Simone E Dekker, Vahagn C Nikolian, Martin Sillesen, Ted Bambakidis, Patrick Schober, Hasan B Alam

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neuroscience research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Simone E DekkerDepartment of Surgery, University of Michigan Hospital, Ann Arbor, Michigan.
Vahagn C NikolianDepartment of Surgery, University of Michigan Hospital, Ann Arbor, Michigan.
Martin SillesenDepartment of Surgical Gastroenterology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Ted BambakidisDepartment of Surgery, University of Michigan Hospital, Ann Arbor, Michigan.
Patrick SchoberDepartment of Anesthesiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, the Netherlands.
Hasan B AlamDepartment of Surgery, University of Michigan Hospital, Ann Arbor, Michigan.ORCID 0000-0002-1024-5226
University of Michigan · USAmsterdam UMC Location Vrije Universiteit Amsterdam · NLCopenhagen University Hospital · DK

Funding

Modulation of Acetylation in the Treatment of Lethal InjuriesR01GM084127 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALAM, HASAN B · 2009 to 2019
$2.6M
NIGMS NIH HHS R01 GM084127
6 · The paper itself

Abstract

Traumatic brain injury (TBI) is a leading cause of death in young adults, and effective treatment strategies have the potential to save many lives. TBI results in coagulopathy, endothelial dysfunction, inflammation, cell death, and impaired epigenetic homeostasis, ultimately leading to morbidity and/or mortality. Commonly used resuscitation fluids such as crystalloids or colloids have several disadvantages and might even be harmful when administered in large quantities. There is a need for next-generation treatment strategies (especially in the prehospital setting) that minimize cellular damage, improve survival, and enhance neurological recovery. Pharmacologic treatment with histone deacetylase inhibitors, such as valproic acid, has shown promising results in animal studies of TBI and may therefore be an excellent example of next-generation therapy. This review briefly describes traditional resuscitation strategies for TBI combined with hemorrhagic shock and describes preclinical studies on valproic acid as a new pharmacologic agent in the treatment of TBI. It finally discusses limitations and future directions on the use of histone deacetylase inhibitors for the treatment of TBI.

Indexed as

AcetylationBrain Injuries, TraumaticEpigenesis, GeneticHistone Deacetylase InhibitorsHumansResuscitationShock, HemorrhagicValproic AcidHistone Deacetylase InhibitorsValproic Acidhistone deacetylase inhibitorresuscitationtraumatic brain injuryvalproic acid

Identifiers

PMID28742231
PMCPMC5785554
OpenAlexW2738945249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.